Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,87 USD | +4,73% | +0,29% | +35,24% |
Attività
Numero di dipendenti: 49
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Radiotherapies
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 60 | 01/03/12 |
Steve O'Loughlin
DFI | Director of Finance/CFO | 39 | 13/10/15 |
Akash Nahar
CTO | Chief Tech/Sci/R&D Officer | - | 27/10/22 |
Monideepa Roy
CTO | Chief Tech/Sci/R&D Officer | - | 27/09/21 |
Mary Mei Chen
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/20 |
Avinash Desai
CTO | Chief Tech/Sci/R&D Officer | - | 19/11/20 |
Stephen Dressel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Jenny Hsieh
PRN | Corporate Officer/Principal | - | - |
Paul Diamond
LAW | General Counsel | - | 01/07/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 66 | 08/11/13 | |
C. Nicholson
BRD | Director/Board Member | 68 | 01/01/08 |
Ajit Shetty
BRD | Director/Board Member | 77 | 28/03/17 |
Sandesh Seth
CEO | Chief Executive Officer | 60 | 01/03/12 |
Jeffrey Chell
BRD | Director/Board Member | 70 | 01/04/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 29 396 411 | 28 760 771 ( 97,84 %) | 0 | 97,84 % |
Coordinate società
Actinium Pharmaceuticals, Inc.
100 Park Avenue 23rd floor
10017, New York
+646 677 3870
http://www.actiniumpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+35,24% | 202 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione ATNM
- Società Actinium Pharmaceuticals, Inc.